Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Recruiting · NCT05672927 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 4 | 2026-09-15 | NCT05672927 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer Prevention Research Institute of Texas | 29 |
| The University of Texas Medical Branch, Galveston | 59 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Texas Medical Branch | Galveston | United States | 45 |